Renal Sympathetic-Nerve Ablation for Uncontrolled Hypertension
Open accessThe DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Abstract
evidence of the efficacy of bevacizumab in patients with HHT.Both cases also show that symptoms and transfusion requirements improve with this therapy, without an appreciable change in arteriovenous malformations.Like Oosting et al., we found no difference in the size of our patient's pulmonary arteriovenous malformations on CT before and after bevacizumab.Their experience demonstrates the long-term safety and tolerability of bevacizumab in such patients.Our patient continues to report symptomatic benefit more than a year after completing therapy, and he has required only one intravenous infusion of iron during this time.His hemoglobin levels have remained stable at 14 to 15 g per deciliter.The cost of our patient's regimen (a total of 30 mg per kilogram over four cycles) would be approximately $12,000 today.The costs of continuing the drug in the long term, especially without a Food and Drug Administration-approved indication, would be prohibitive.Our case shows that intermittent dosing allows for long-term, symptomatic improvement and stability of pulmonary arteriovenous malformations.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In this patient, RDN resulted in a progressive decrease in blood pressure from 161/107 mmHg at baseline to 127/81 mmHg at 12-month follow-up.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [18]
In the citing paper
“However, RDN-induced reductions in MSNA18 and beneficial effects of RDN on conditions that are not traditionally thought to be driven by the kidney, including heart failure and arrthymia19, cannot be wholly explained by alterations in body fluid homeostasis.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [18]
In the citing paper
“ablation of the renal nerves was also associated with a substantial decrease in muscle sympathetic nerve activity (MSNA), from 56 bursts per minute before RDN to 19 bursts per minute at 12 months after the procedure.”
From Renal nerves in physiology, pathophysiology and interoception (2025) · cites this paper as [18]
In the citing paper
“The hypothesis that renal afferents mediate some of the BP effects of RDN in humans was sparked by the finding that whole-body noradrenaline spillover and MSNA were decreased in a single patient 1 year after RDN170.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [170]
Citations
Cites
Krum, H., Schlaich, M., Whitbourn, R., Sobotka, P. A., Sadowski, J., Bartus, K., Kapelak, B., Walton, A., Sievert, H., Thambar, S., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60566-3 · Cited by 2,108
Self-citationNeural control of renal function
DiBona, G. F., & Kopp, U. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.1.75 · Cited by 1,212
Sympathetic Overactivity in Patients with Chronic Renal Failure
Converse, R. L., Jacobsen, T. N., Toto, R. D., Jost, C. M. T., Cosentino, F., Fouad-Tarazi, F., & Victor, R. G. (1992) · New England Journal of Medicine · doi:10.1056/nejm199212313272704 · Cited by 1,132
Schlaich, M. P., Lambert, E., Kaye, D. M., Krozowski, Z., Campbell, D. J., Lambert, G., Hastings, J., Aggarwal, A., & Esler, M. D. (2004) · Hypertension · doi:10.1161/01.hyp.0000103160.35395.9e · Cited by 514
Self-citationNoradrenaline Release and the Pathophysiology of Primary Human Hypertension
Esler, M., Jennings, G., & Lambert, G. (1989) · American Journal of Hypertension · doi:10.1093/ajh/2.3.140s · Cited by 138
Self-citation
Cited by
Items 101–200 of 763
Renal Denervation and Hypertension
Schlaich, M. P., Krum, H., Sobotka, P. A., & Esler, M. D. (2011) · American Journal of Hypertension · doi:10.1038/ajh.2011.35 · Cited by 73
Self-citationRenal denervation: symply trapped by complexity?
Mahfoud, F., & Lüscher, T. F. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu450 · Cited by 66
Renal sympathetic denervation therapy in the real world: results from the Heidelberg registry
Vogel, B., Kirchberger, M. C., Zeier, M. G., Stoll, F., Meder, B., Saure, D., Andrassy, M., Mueller, O. J., Hardt, S. E., Schwenger, V., et al. (2013) · Clinical Research in Cardiology · doi:10.1007/s00392-013-0627-5 · Cited by 66
“Renal denervation therapy was shown to be safe and effective in patients with treatment-resistant hypertension [9, 11–15].”
BackgroundMethodRenal Denervation for Resistant Hypertension?
Messerli, F. H., & Bangalore, S. (2014) · New England Journal of Medicine · doi:10.1056/nejme1402388 · Cited by 65
Vascular and Renal Hemodynamic Changes after Renal Denervation
Ott, C., Janka, R., Schmid, A., Titze, S. I., Ditting, T., Sobotka, P. A., Veelken, R. A., Uder, M., & Schmieder, R. E. (2013) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.08500812 · Cited by 68
Self-citationThe Sympathetic Nervous System in Obesity Hypertension
Lohmeier, T. E., & Iliescu, R. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0356-1 · Cited by 62
“The decrease in preglomerular resistance in this study is consistent with a reported 56 % increase in renal plasma flow immediately following renal nerve ablation in a patient with resistant hypertension [23].”
Rey-García, J., & Townsend, R. R. (2022) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2022.03.015 · Cited by 74
Cardiac sympathetic dysfunction in the prehypertensive spontaneously hypertensive rat
Shanks, J. A., Manou-Stathopoulou, S., Lu, C., Li, D., Paterson, D. J., & Herring, N. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00255.2013 · Cited by 65
Renal Denervation and Heart Failure
Böhm, M., Ewen, S., Kindermann, I., Linz, D., Ukena, C., & Mahfoud, F. (2014) · European Journal of Heart Failure · doi:10.1002/ejhf.83 · Cited by 61
Hart, E. C., McBryde, F. D., Burchell, A. E., Ratcliffe, L. E. K., Stewart, L. Q., Baumbach, A., Nightingale, A. K., & Paton, J. F. R. (2013) · Hypertension · doi:10.1161/hypertensionaha.113.01261 · Cited by 65
“It has been hypothesized that decreased renal afferent input into the brain stem reduces reflex-evoked increases in both sympathetic nerve activity (SNA) and BP.(20) In this context, selective renal afferent denervation (dorsal rhizotomy) in rats with chronic renal failure abolishes hypertension in these animals.”
BackgroundInfluentialDevice Therapy of Hypertension
Mahfoud, F., Schlaich, M. P., & Lobo, M. D. (2021) · Circulation Research · doi:10.1161/circresaha.121.318091 · Cited by 60
Self-citationWang, X., Zhao, Q., Huang, H., Tang, Y., Xiao, J., Dai, Z., Yu, S., & Huang, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064611 · Cited by 63
Brain angiotensin peptides regulate sympathetic tone and blood pressure
Dupont, A. G., & Brouwers, S. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e32833af3b2 · Cited by 67
Asferg, C. L., Nielsen, S. J., Andersen, U. B., Linneberg, A., Møller, D. V., Hedley, P. L., Christiansen, M., Goetze, J. P., Esler, M., & Jeppesen, J. L. (2013) · Hypertension · doi:10.1161/hypertensionaha.111.00791 · Cited by 58
Self-citationEffects of Renal Sympathetic Denervation on 24-hour Blood Pressure Variability
Zuern, C. S., Rizas, K. D., Eick, C., Stoleriu, C., Bunk, L., Barthel, P., Balletshofer, B. M., Gawaz, M., & Bauer, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00134 · Cited by 66
“RDN reduces whole body norepinephrine spillover by 42% and efferent muscle sympathetic nerve activity by 66% (Schlaich et al., 2009).”
BackgroundDörr, O., Liebetrau, C., Möllmann, H., Lorenz, J., Gaede, L., Troidl, C., Rixe, J., Hamm, C. W., & NEF, H. M. (2014) · Hypertension · doi:10.1161/hypertensionaha.113.02266 · Cited by 64
“In addition, it has been reported that RSD reduces the renal sympathetic efferent activity and the sympathetic nerve traffic to the skeletal muscle vasculature as measured by muscle sympathetic nerve activity.(23,35) Therefore, the combined analysis of the sympathetic activity and measurement of ICAM-1, VCAM-1, and sF…”
BackgroundCohort Profile: The Saguenay Youth Study (SYS)
Pausova, Z., Paus, T., Abrahamowicz, M., Bernard, M., Gaudet, D., Leonard, G., Peron, M., Pike, G. B., Richer, L., Séguin, J. R., et al. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw023 · Cited by 57
The role of oxidative stress in renovascular hypertension
Campos, R. R., Oliveira‐Sales, E. B., Nishi, E. E., Boim, M. A., Dolnikoff, M. S., & Bergamaschi, C. T. (2010) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2010.05437.x · Cited by 64
“Indeed, ablation to excise renal nerves that carry both efferent sympathetic and afferent sensory fibers reduced blood pressure and renal norepinephrine spillover in patients with essential hypertension resistant to pharmacological treatment.(56) Chronic renal hypoxia has been considered an underlying cause of progres…”
BackgroundTain, Y., & Hsu, C. (2022) · Antioxidants · doi:10.3390/antiox11030511 · Cited by 66
“In view of the introduction of renal sympathetic denervation into clinical medicine that has demonstrated marked reductions in BP in patients with resistant hypertension [56], there has been interest in interorgan crosstalk involving various regulatory hormones contributing to hypertension that more closely reflects t…”
BackgroundKatayama, T., Sueta, D., Kataoka, K., Hasegawa, Y., Koibuchi, N., Toyama, K., Uekawa, K., MingJie, M., Nakagawa, T., Maeda, M., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000197 · Cited by 57
Renal denervation for treatment of drug-resistant hypertension
Esler, M. (2015) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.09.014 · Cited by 55
Self-citationCentral sympathetic nerve activation in subarachnoid hemorrhage
Hasegawa, Y., Uchikawa, H., Kajiwara, S., & Morioka, M. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15511 · Cited by 58
“Recently, renal denervation (RD) has been reported to improve treatment- resistant hypertension, and the effect was associated with reduction of CSN activity (Esler et al., 2010; Schlaich et al., 2009).”
BackgroundNakagawa, T., Hasegawa, Y., Uekawa, K., Ma, M., Katayama, T., Sueta, D., Toyama, K., Kataoka, K., Koibuchi, N., Maeda, M., et al. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000375 · Cited by 56
“Furthermore, it has been demonstrated that muscle sympathetic nerve activity and systemic norepinephrine spillover are significantly reduced after RD in a single patient with resistant hypertension.(9) RD reduces left ventricular hypertrophy and improves cardiac function(10) in patients with resistant hypertension.”
BackgroundKumar, S., Tedrow, U. B., & Stevenson, W. G. (2017) · Circulation Arrhythmia and Electrophysiology · doi:10.1161/circep.116.003676 · Cited by 55
Recurrent Postural Vasovagal Syncope: Sympathetic Nervous System Phenotypes
Vaddadi, G., Guo, L., Esler, M., Socratous, F., Schlaich, M., Chopra, R., Eikelis, N., Lambert, G., Trauer, T., & Lambert, E. (2011) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.111.962332 · Cited by 54
Self-citationHuang, B. S., Yu, L., Scherlag, B. J., Wang, S., He, B., Yang, K., Liao, K., Lu, Z., He, W., Zhang, L., et al. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12498 · Cited by 55
Dorenkamp, M., Bonaventura, K., Leber, A. W., Boldt, J., Sohns, C., Boldt, L., Haverkamp, W., Frei, U. A., & Roser, M. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs355 · Cited by 59
“One recent approach relies on a percutaneous, catheter-based procedure that selectively targets and disrupts renal sympathetic nerves using radiofrequency energy.(9) Clinical safety and efficacy studies of renal sympathetic denervation (RDN) have shown substantial reductions of blood pressure without serious procedure…”
BackgroundKiuchi, M. G., Chen, S., Hoye, N. A., & Pürerfellner, H. (2017) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-017-0302-2 · Cited by 57
Seravalle, G., Mancia, G., & Grassi, G. M. (2014) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-014-0056-1 · Cited by 61
“intervention are associated with (and possibly triggered by) its sympatholytic effects, as indicated by reduction in total body and renal norepinephrine spillover as well as in sympathetic nerve traffic values [113].”
BackgroundElia, A., & Fossati, S. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1060666 · Cited by 58
Effects of renal sympathetic denervation on the stellate ganglion and brain stem in dogs
Tsai, W.-C., Chan, Y.-H., Chinda, K., Chen, Z., Patel, J., Shen, C., Zhao, Y., Jiang, Z., Yuan, Y., Ye, M., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2016.10.003 · Cited by 52
Zhang, W., Zhou, Q., Lu, Y., Li, Y., Zhang, L., Zhang, J., Xing, Q., Lv, W., Cheng, X., Zhang, G., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.009938 · Cited by 51
“RDN simultaneously reduces whole-body norepinephrine spillover by 42% and muscle SN activity, which highlights the possibility that inhibition of afferent renal nerve activity may contribute to a reduction in the central sympathetic drive.(11) Based on these findings, subsequent clinical studies have used RDN in refra…”
ResultEffects of sympathetic modulation in metabolic disease
Carnagarin, R., Lambert, G. W., Kiuchi, M. G., Nolde, J. M., Matthews, V. B., Eikelis, N., Lambert, É., & Schlaich, M. P. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14217 · Cited by 56
Self-citationLinz, D., Mahfoud, F., Schotten, U., Ukena, C., Neuberger, H., WIRTH, K. J., & Böhm, M. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12171 · Cited by 52
Relationships of Adrenoceptor Polymorphisms with Obesity
Masuo, K., & Lambert, G. W. (2011) · Journal of Obesity · doi:10.1155/2011/609485 · Cited by 56
“Given these observations and the recent demonstration of the effectiveness of catheter based sympathetic renal denervation for the treatment of refractory hypertension [114, 115], it may be of importance to aim antihypertensive treatments or anti-diabetic treatment not only at the reduction of raised blood pressure or…”
BackgroundVoskuil, M., Verloop, W. L., Blankestijn, P. J., Agostoni, P., Stella, P. R., & Doevendans, P. A. (2011) · Netherlands Heart Journal · doi:10.1007/s12471-011-0143-z · Cited by 55
“Using the World Health Organisation criteria of 2001 (systolic blood pressure ≥140 mmHg and/or a diastolic blood pressure ≥90 mmHg), 34% of adult men and 30% of women in the Netherlands suffer from hypertension [ 1 ].”
BackgroundRenal denervation for the treatment of resistant hypertension: review and clinical perspective
Iliescu, R., Lohmeier, T. E., Tudorancea, I., Laffin, L., & Bakris, G. L. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00246.2015 · Cited by 50
“The decrease in preglomerular resistance in this study is consistent with a reported 56% increase in renal plasma flow immediately following renal nerve ablation in a patient with resistant hypertension (77).”
Sympathetic Hyperactivity in Chronic Kidney Disease: Pathophysiology and (New) Treatment Options
Vink, E. E., de Jager, R. L., & Blankestijn, P. J. (2013) · Current Hypertension Reports · doi:10.1007/s11906-013-0328-5 · Cited by 53
Novel procedure- and device-based strategies in the management of systemic hypertension
Krum, H., Schlaich, M. P., Sobotka, P. A., Scheffers, I., Kroon, A. A., & de Leeuw, P. W. (2011) · European Heart Journal · doi:10.1093/eurheartj/ehq457 · Cited by 53
Self-citationEligibility for percutaneous renal denervation: the importance of a systematic screening
Verloop, W. L., Vink, E. E., Voskuil, M., Vonken, E.-J. P. A., Rookmaaker, M. B., Bots, M. L., Doevendans, P. A., Blankestijn, P. J., & Spiering, W. (2013) · Journal of Hypertension · doi:10.1097/hjh.0b013e328362152e · Cited by 57
“In this context, a percutaneous, catheter-based approach has been developed to disrupt the renal sympathetic nerves, using radiofrequency energy [5].”
MethodTreatment Strategies for Resistant Arterial Hypertension
Mahfoud, F., Himmel, F., Ukena, C., Schunkert, H., Böhm, M., & Weil, J. (2011) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2011.0725 · Cited by 64
Kario, K., Bhatt, D. L., Brar, S., Cohen, S. A., Fahy, M., & Bakris, G. L. (2015) · Hypertension · doi:10.1161/hypertensionaha.115.06260 · Cited by 49
Osborn, J. W., & Banek, C. T. (2018) · Hypertension · doi:10.1161/hypertensionaha.117.08928 · Cited by 49
“In 1 case report, multi-unit MSNA decreased from 56 bursts/min to 41 bursts/min 1 month after CBRNA and 19 bursts/min 12 months thereafter.(27) Another study did not find a reduction in MSNA after CBRNA, but they also did not observe a decrease in arterial pressure.”
Hypertension in obesity: is leptin the culprit?
Simonds, S. E., & Cowley, M. A. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.01.004 · Cited by 53
Renal Denervation in Human Hypertension: Mechanisms, Current Findings, and Future Prospects
Schlaich, M. P., Hering, D., Sobotka, P. A., Krum, H., & Esler, M. (2012) · Current Hypertension Reports · doi:10.1007/s11906-012-0264-9 · Cited by 49
Self-citationTonic Postganglionic Sympathetic Inhibition Induced by Afferent Renal Nerves?
Ditting, T., Freisinger, W., Siegel, K., Fiedler, C., Small, L., Neuhuber, W., Heinlein, S., Reeh, P. W., Schmieder, R. E., & Veelken, R. A. (2012) · Hypertension · doi:10.1161/hypertensionaha.111.185538 · Cited by 53
“6, 10, 33*10 7 M; 10 L; after 15, 30, 45, and 60 minutes, respectively) to stimulate afferent renal nerve activity; (3) right-sided bipolar electrode for continuous renal sympathetic nerve recording; and (4) specialized renal pelvic and renal artery catheters to separate pelvic from intrarenal afferent activity.”
BackgroundMethodRenal Sympathetic Nerve Ablation: The New Frontier in the Treatment of Hypertension
Schlaich, M. P., Krum, H., & Sobotka, P. A. (2010) · Current Hypertension Reports · doi:10.1007/s11906-009-0078-6 · Cited by 50
Self-citationWhite, L. H., Bradley, T. D., & Logan, A. G. (2014) · Journal of Human Hypertension · doi:10.1038/jhh.2014.94 · Cited by 57
Hoffmann, B. A., Steven, D., Willems, S., & Sydow, K. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12207 · Cited by 54
Catheter-Based Renal Denervation Exacerbates Blood Pressure Fall During Hemorrhage
Singh, R. R., Sajeesh, V., Booth, L. C., McArdle, Z., May, C. N., Head, G. A., Moritz, K. M., Schlaich, M. P., & Denton, K. M. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2016.12.014 · Cited by 46
“Our findings were consistent with those in resistant hypertensive populations following RDN (25) in which heart rate was reduced following RDN and might be a consequence of the loss of renal afferent sympathoexcitatory input following RDN, leading to a global reduction in sympathetic outflow (26).”
ResultSelf-citationRenal nerves in physiology, pathophysiology and interoception
Evans, L. C., Dayton, A., & Osborn, J. W. (2025) · Nature Reviews Nephrology · doi:10.1038/s41581-024-00893-3 · Cited by 46
“Clinical studies have demonstrated that RDN decreases systemic sympathetic tone, which was shown most clearly by evaluating MSNA.”
InfluentialThe Cardiorenal Syndrome: A Review
Shah, B. N., & Greaves, K. (2010) · International Journal of Nephrology · doi:10.4061/2011/920195 · Cited by 51
Tsioufis, C. P., Dimitriadis, K. S., Kasiakogias, A., Kalos, T., Liatakis, I., Koutra, E., Nikolopoulou, L., Kordalis, A., Ella, R. O., Lau, E., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001262 · Cited by 50
Renal Sympathetic Nerve-Derived Signaling in Acute and Chronic Kidney Diseases
Noh, M. R., Jang, H., Kim, J., & Padanilam, B. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051647 · Cited by 52
“The renal sympathetic nervous system has drawn increasing interest over many years, after the introduction of renal sympathetic denervation into clinical medicine [19,20].”
BackgroundPatel, H. C., Rosen, S. D., Lindsay, A. C., Hayward, C., Lyon, A. R., & Mario, C. D. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.058 · Cited by 50
“By showing reduced MSNA after renal artery denervation, researchers were able to show that although the procedure targets only the renal sympathetic nerves its effects extend to the CNS and other organ beds including skeletal muscle [21].”
BackgroundPerirenal adipose afferent nerves sustain pathological high blood pressure in rats
Li, P., Liu, B., Wu, X., Lu, Y., Qiu, M., Shen, Y., Tian, Y., Liu, C., Chen, X., Yang, C., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30868-6 · Cited by 53
Neuroimmune communication in hypertension and obesity: A new therapeutic angle?
de Kloet, A. D., Krause, E. G., Shi, P. D., Zubcevic, J., Raizada, M. K., & Sumners, C. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.02.005 · Cited by 46
“…have increased sympathetic outflow, parasympathetic withdrawal, and norepinephrine spillover, and surgical denervation of the kidney has shown promise as an effective intervention for these patients (Krum et al., 2009; Schlaich et al., 2009a, 2009b; Esler et al., 2010; Schlaich et al., 2012).”
BackgroundThaung, H. P. A., Baldi, J. C., Wang, H.-Y., Hughes, G., Cook, R. F., Bussey, C. T., Sheard, P. W., Bahn, A., Jones, P. P., Schwenke, D. O., et al. (2015) · Diabetes · doi:10.2337/db14-0955 · Cited by 45
“Identifying the underlying processes of diabetic autonomic dysfunction is important, as the traditional treatment of patients with type 2 diabetes with b-blockers is of benefit, although to a lesser extent than in the treatment of nondiabetic patients (25), and it is even more critical for the development of potential…”
BackgroundVerloop, W. L., Beeftink, M. M. A., Nap, A., Bots, M. L., Velthuis, B. K., Appelman, Y., Cramer, M. J., Agema, W. R. P., Scholtens, A. M., Doevendans, P. A., et al. (2013) · European Journal of Heart Failure · doi:10.1093/eurjhf/hft119 · Cited by 49
“Recent studies showed that decreasing sympathetic nerve activity from and to the kidneys using pRDN results in a clinically significant reduction of blood pressure in patients with so-called therapy-resistant hypertension.(44) Renal denervation appears to be a safe and relatively easy minimally invasive technique to i…”
BackgroundAutonomic control of ventricular function in health and disease: current state of the art
van Weperen, V. Y. H., Ripplinger, C. M., & Vaseghi, M. (2023) · Clinical Autonomic Research · doi:10.1007/s10286-023-00948-8 · Cited by 50
Tsioufis, C. P., Papademetriou, V., Dimitriadis, K. S., Tsiachris, D., Thomopoulos, C., Park, E., Hata, C., Papalois, A. E., & Stefanadis, C. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.038 · Cited by 48
“Percutaneous catheter-based techniques that can induce renal sympathetic denervation (RSD) in humans are emerging as a viable approach to achieve sustained blood pressure reduction in patients with resistant hypertension, without unfavorable effects on renal function [1,13–16].”
BackgroundResultInfluentialAdvances in the Treatment Strategies in Hypertension: Present and Future
Verdecchia, P., Cavallini, C., & Angeli, F. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9030072 · Cited by 51
“Several mech nistic studies have demonstrated that ablation of efferent and afferent renal n rves s followed by a reduction of the neural ‘bursts’ of sympathetic activity, detectable by neurography, with parallel reduction in BP [90].”
BackgroundResponse and non-response to renal denervation: who is the ideal candidate?
Ukena, C., Cremers, B., Ewen, S., Böhm, M., & Mahfoud, F. (2013) · EuroIntervention · doi:10.4244/eijv9sra10 · Cited by 45
Epstein, M., & de Marchena, E. (2014) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2014.12.002 · Cited by 49
Romanov, A., Pokushalov, E. A., Ponomarev, D., Григорьевич, С. А., Шабанов, В. В., Losik, D., Karaskov, A. M., & Steinberg, J. S. (2017) · Cardiovascular Therapeutics · doi:10.1111/1755-5922.12264 · Cited by 46
Tanaka, R., Tsutsui, H., Kobuchi, S., Sugiura, T., Yamagata, M., Ohkita, M., Takaoka, M., Yukimura, T., & Matsumura, Y. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.02.044 · Cited by 45
Cardiovascular Risk in Chronic Kidney Disease: Role of the Sympathetic Nervous System
Park, J. (2012) · Cardiology Research and Practice · doi:10.1155/2012/319432 · Cited by 49
“[86] M.”
BackgroundEffects of Renal Artery Denervation on Ventricular Arrhythmias in a Postinfarct Model
Jackson, N. M., Gizurarson, S., Azam, M. A., King, B., Ramadeen, A., Zamiri, N., Porta‐Sánchez, A., Al‐Hesayen, A., Graham, J. J., Kusha, M., et al. (2017) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.116.004172 · Cited by 42
“Reduction in mean and peak heart rates in association with reduced spontaneous VAs after RDN may both relate to lowered whole-body sympathetic activity mediated by a reduction in renal afferent nerve activity.(16) Conversely, faster heart beats may exacerbate the Figure 6.”
BackgroundResultRenal denervation for hypertension
Fisher, N. D. L., & Kirtane, A. J. (2025) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01104-z · Cited by 45
“Novel technologies effecting percutaneous sympathetic renal denervation (RDN) began to show promise in the 1990s 9,10 .”
InfluentialMyat, A., Redwood, S. R., Qureshi, A. C., Thackray, S. D. R., Cleland, J. G. F., Bhatt, D. L., Williams, B., & Gersh, B. J. (2013) · Circulation Cardiovascular Interventions · doi:10.1161/circinterventions.112.000037 · Cited by 44
“Renal norepinephrine spillover (measure of renal efferent activity), total body norepinephrine spillover (measure of central sympathetic drive via the renal afferent pathway), and microneurography (measure of muscle sympathetic nerve activity) are metrics that could have been used to evaluate the durability of effect,…”
MethodRenal denervation for hypertension: observations and predictions of a founder
Esler, M. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu091 · Cited by 40
Self-citationLinz, D., Mahfoud, F., Linz, B. M., Hohl, M., Schirmer, S. H., WIRTH, K. J., & Böhm, M. (2014) · American Journal of Hypertension · doi:10.1093/ajh/hpu036 · Cited by 45
Role of Phosphodiesterase 5 and Cyclic GMP in Hypertension
Mergia, E., & Stegbauer, J. (2016) · Current Hypertension Reports · doi:10.1007/s11906-016-0646-5 · Cited by 40
Mild DOCA-salt hypertension: sympathetic system and role of renal nerves
Kandlikar, S. S., & Fink, G. D. (2011) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00972.2010 · Cited by 42
A sympathetic view of human obesity
Lambert, É., Straznicky, N. E., & Lambert, G. W. (2012) · Clinical Autonomic Research · doi:10.1007/s10286-012-0169-3 · Cited by 40
Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension
Papademetriou, V., Doumas, M. N., & Tsioufis, K. P. (2011) · International Journal of Hypertension · doi:10.4061/2011/196518 · Cited by 43
“Further insights into mechanisms of hypertension control through RSD were published in a recent case report of a 59-year old patient with long-standing uncontrolled hypertension on a multidrug regimen [29].”
BackgroundAutonomic Dysfunction in Diabetes: a Consequence of Cardiovascular Damage
Lefrandt, J. D., Smit, A. J., Zeebregts, C. J., Gans, R. O. B., & Hoogenberg, K. (2010) · Current Diabetes Reviews · doi:10.2174/157339910793499128 · Cited by 40
Selective vs. Global Renal Denervation: a Case for Less Is More
Fudim, M., Sobotka, A., Yin, Y., Wang, J. W., Levin, H. R., Esler, M., Wang, J., & Sobotka, P. A. (2018) · Current Hypertension Reports · doi:10.1007/s11906-018-0838-2 · Cited by 39
Self-citationMathis, K. W., Venegas-Pont, M., Flynn, E. R., Williams, J. M., Maric-Bilkan, C., Dwyer, T. M., & Ryan, M. J. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00602.2012 · Cited by 39
Shantha, G. P. S., & Pancholy, S. B. (2014) · Sleep And Breathing · doi:10.1007/s11325-014-0991-z · Cited by 44
“Renal sympathetic denervation (RDN), by administering discrete, low-dose radiofrequency energy to the renal artery endothelial surface via a percutaneous catheter-based procedure, is shown to reduce renal sympathetic outflow by severing the sympathetic nerve supply to the kidney, which in turn leads to decreased syste…”
BackgroundAmbulatory arterial stiffness index as a predictor of blood pressure response to renal denervation*
Sata, Y., Hering, D., Head, G. A., Walton, A. S., Peter, K., Marusic, P., Duval, J., Lee, R., Hammond, L. J., Lambert, E. A., et al. (2018) · Journal of Hypertension · doi:10.1097/hjh.0000000000001682 · Cited by 37
“Renal denervation (RDN) has been demonstrated to decrease BP at least in part through the interruption of the neural network of renal nerves in patients with resistant hypertension [3].”
BackgroundMethodSelf-citationAdvances in the Pathogenesis and Treatment of Resistant Hypertension
Dybiec, J., Krzemińska, J., Radzioch, E., Szlagor, M., Wronka, M., Młynarska, E., Rysz, J., & Franczyk, B. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612911 · Cited by 47
“The result of RDN is a reduction in sympathetic activity and, therefore, a decrease in renin activity and an increase in renal blood flow [52].”
BackgroundHering, L., Rahman, M., Potthoff, S. A., Rump, L. C., & Stegbauer, J. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.566871 · Cited by 40
Kiuchi, M. G., Ho, J. K., Nolde, J. M., Gavidia, L. M. L., Carnagarin, R., Matthews, V. B., & Schlaich, M. P. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2019.01546 · Cited by 36
Self-citationEffects of carotid body tumor resection on the blood pressure of essential hypertensive patients
Fudim, M., Groom, K. L., Laffer, C. L., Netterville, J. L., Robertson, D., & Elijovich, F. (2015) · Journal of the American Society of Hypertension · doi:10.1016/j.jash.2015.03.006 · Cited by 39
Management of patients with resistant hypertension: current treatment options
Dudenbostel, T., Kumar, N., & Calhoun (2013) · Integrated Blood Pressure Control · doi:10.2147/ibpc.s33984 · Cited by 36
“Cardiac magnetic resonance imaging 12 months after the procedure showed a decrease in left ventricular mass of 9%.(97) A follow-up study at 24 months of SYMPLICITY HTN-1 showed a BP reduction of 32/14 mmHg, thus demonstrating the long-term antihypertensive effect of RDN.”
Tomey, M. I., & Winston, J. A. (2014) · Annals of Global Health · doi:10.1016/j.aogh.2013.12.007 · Cited by 45
Catheter-based Radiofrequency Renal-nerve Ablation in Patients with Resistant Hypertension
Azizi, M., Steichen, O., Frank, M., Bobrie, G., Plouin, P., & Sapoval, M. R. (2012) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2011.11.022 · Cited by 40
The rise, fall, and possible resurrection of renal denervation
Gulati, R., Raphael, C. E., Negoita, M., Pocock, S., & Gersh, B. J. (2016) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2016.1 · Cited by 42
Hoogerwaard, A. F., de Jong, M. R., Adiyaman, A., Smit, J. J. J., Delnoy, P. P. H. M., Heeg, J., van Hasselt, B. A. A. M., Misier, A. R. R., Rienstra, M., Gelder, I. C. V., et al. (2018) · Clinical Research in Cardiology · doi:10.1007/s00392-018-1307-2 · Cited by 36
Effect of healthy aging on renal vascular responses to local cooling and apnea
Patel, H. M., Mast, J. L., Sinoway, L. I., & Muller, M. D. (2013) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00089.2013 · Cited by 36
Hypertension in Small Animal Kidney Disease
Syme, H. M. (2011) · Veterinary Clinics of North America Small Animal Practice · doi:10.1016/j.cvsm.2010.11.002 · Cited by 57
Lenski, D., Kindermann, I., Lenski, M., Ukena, C., Bunz, M., Mahfoud, F., & Böhm, M. (2013) · EuroIntervention · doi:10.4244/eijv9i6a114 · Cited by 38
Vink, E. E., & Blankestijn, P. J. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00029 · Cited by 37
“Moreover, renin activity reduced by 50%; renal plasma flow increased with almost 56%; left ventricular mass decreased with almost 9%; and MSNA substantially reduced (Schlaich et al., 2009).”
BackgroundVink, E. E., Verloop, W. L., Siddiqi, L., van Schelven, L. J., Oey, P. L., & Blankestijn, P. J. (2014) · International Journal of Cardiology · doi:10.1016/j.ijcard.2014.06.021 · Cited by 38
“A few studies investigating the effect of RDN on MSNA are recently published, and report mixed effects of RDN on MSNA [18–21].”
BackgroundOrthostatic function after renal sympathetic denervation in patients with resistant hypertension
Lenski, M., Mahfoud, F., Razouk, A., Ukena, C., Lenski, D., Barth, C., Linz, D., Laufs, U., Kindermann, I., & Böhm, M. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2013.10.017 · Cited by 36
“and NE spillover are reduced after RDN, alterations in the activity of the sympathetic nervous system could impair adaption to orthostatic stress [6,24].”
BackgroundTsioufis, C. P., Ziakas, A., Dimitriadis, K. S., Davlouros, P. A., Marketou, M. E., Kasiakogias, A., Thomopoulos, C., Petroglou, D., Tsiachris, D., Doumas, M. N., et al. (2016) · Clinical Research in Cardiology · doi:10.1007/s00392-016-1056-z · Cited by 38
“One of the problematic key issues in RDN therapy is the lack of strong predictors of BP response others than baseline office BP [6, 7, 19, 23, 24].”
BackgroundRosa, J., Widimský, P., Waldauf, P., Zelinka, T., Petrák, O., Táborský, M., Branny, M., Toušek, P., Čurila, K., Lambert, L., et al. (2017) · Journal of Hypertension · doi:10.1097/hjh.0000000000001257 · Cited by 37
Sympathetic Activation in Chronic Kidney Disease: Out of the Shadow
Schlaich, M. P. (2011) · Hypertension · doi:10.1161/hypertensionaha.110.167189 · Cited by 40
Self-citationWang, X., Huang, C., Zhao, Q., Huang, H., Tang, Y., Dai, Z., Wang, X., Guo, Z., & Xiao, J. (2014) · EP Europace · doi:10.1093/europace/euu212 · Cited by 35
Metadata
- Authors
- Schlaich, M. P., Sobotka, P. A., Krum, H., Lambert, E., & Esler, M. D.
- Affiliations
- Baker Heart and Diabetes Institute (AU)
- University of Oklahoma Health Sciences Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2009-08-27
- Volume
- 361
- Issue
- 9
- Pages
- 932-934
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W1994487234
- Cited by
- 772
- References
- 5
- Citations by year
- 2026: 14 · 2025: 15 · 2024: 19 · 2023: 25 · 2022: 22 · 2021: 19 · 2020: 19 · 2019: 27 · 2018: 31 · 2017: 42 · 2016: 42 · 2015: 52 · 2014: 115 · 2013: 136 · 2012: 95
- FWCI
- 42.01
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Genetics (clinical) › Vascular Anomalies and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- uncontrolled hypertension, bevacizumab, hereditary hemorrhagic telangiectasia, pulmonary arteriovenous malformation, intermittent dosing, long-term drug safety, iron requirements
- MeSH terms
- Humans, Hypertension, Kidney, Male, Middle Aged, Norepinephrine, Renal Artery, Sympathectomy, Catheter Ablation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.